Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Andrew Darley | Guy Hewett | Mark Brewer | Michael Hill | Cavendish Research
7 pages
Allergy Therapeutics (AGY): Corp Regulatory update – Phase III birch allergy trial | Elixirr (ELIX): Corp Thriving on change | Telit (TCM): Corp Earnings well protected during COVID slowdown | Tracsis (TRCS): Corp Worst case avoided
Companies: ACN 4373 CTSH STEM SAG ELIX 0DNH 6560 3697 3915 6532 0HAZ BRNL 9556 4722 4307
Companies: Tracsis plc
Companies: Elixirr International Plc
Companies: SYGGFTUINSDYXARPRMSGMMEGPAGLAGYEMRTSTLCTHCNSLTCGSFRSDIDOTDBVXPCOGYGENABZAOPTIGLEMTFBIHCOTBSTXRTHMAVCTLDRUFDVLAKR
Companies: RUA FEN ING MRL PULS ELIX S247
